Kyorin Pharmaceutical Licenses KRP-M223 to Novartis for Global Development
Japan-based Kyorin Pharmaceutical Co., Ltd. announced a licensing agreement with Novartis (NYSE: NVS), granting the...
Company
GSK’s Depemokimab Accepted for FDA Review as Ultra-Long-Acting Biologic
GSK plc (LON: GSK, NYSE: GSK) announced that the US Food and Drug Administration (FDA)...
Juvestar and Raziel Therapeutics Launch Phase III Study for RZL-012 in China
Juvestar Biotech Co., Ltd., a subsidiary of China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA:...
Waters and Kehua’s LC-MS Systems Gain NMPA Approval for IVD Use
Two home-grown liquid chromatography with tandem mass spectrometry (LC-MS) systems, the ACQUITY UPLC I-Class PLUS...
Zai Lab’s Augtyro Receives TFDA Approval for ROS1-Positive NSCLC and NTRK Fusion Solid Tumors
China-based biotech Zai Lab Ltd (NASDAQ: ZLAB, HKG: 9688) announced that it has received marketing...
Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital
China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a...
Bayer HealthCare and JD Healthcare Partner on Women’s Health Ecosystem
German pharmaceutical giant Bayer HealthCare (ETR: BAYN) has entered into a new partnership with JD...
Huadong Medicine’s HDM1005 Receives NMPA Approval for Clinical Trials
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that it has received clinical trial approval...
Bio-heart’s Iberis RDN System Completes First Commercial Surgery in Germany
China-based Shanghai Bio-heart Biological Technology Co., Ltd (HKG: 2185) announced the successful completion of its...
Geneseeq and MGI Tech Form Global Partnership for Oncology Solutions
Geneseeq Technology Inc., a genetic cancer testing service provider operating in Canada and China, has...
Tonghua Dongbao’s Tongboli Under GMP Inspection in Egypt
China-based Tonghua Dongbao Pharmaceuticals (SHA: 600867) announced that the on-site Good Manufacturing Practice (GMP) inspection...
United Laboratories’ UBT251 Receives FDA Green Light for Phase II CKD Study
Hong Kong-based United Laboratories International Holdings Ltd (HKG: 3933) announced that it has received approval...
CStone Pharmaceuticals Doses First Patient in CS2009 Phase I Study for Solid Tumors
China-based CStone Pharmaceuticals (HKG: 2616) announced the first patient dosing in a global, multi-center Phase...
AbbVie Enters Obesity Field with Gubra’s GUB014295 Licensing Deal
US pharmaceutical giant AbbVie (NYSE: ABBV) announced that it is making significant progress in the...
Zeiss Group’s VISUMAX 800 with SMILE pro Software Approved by China’s NMPA
Germany-based Zeiss Group, a specialist in optical systems and optoelectronic product manufacturing, announced that it...
Laekna’s LAE120 Receives FDA Approval for Solid Tumor Clinical Trials
Sino-US biotech company Laekna, Inc. (HKG: 2105) announced that it has received clinical trial approval...
SynerK’s SNK-2726 Gets FDA Green Light for Phase I Hypertension Study
SynerK, an RNA-targeted therapy developer with operations in Boston, US, and Beijing and Suzhou, China,...
Omron Healthcare and China Jo-Jo Drugstores Launch Atrial Fibrillation Screening Zone
A joint effort between Japan-based Omron Healthcare and China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD), a...
WORK Medical and Chartwell Med Partner on Investment Tools for Healthcare Projects
WORK Medical Technology Group Ltd (NASDAQ: WOK), a medical consumables company based in Hangzhou, has...
Innovent Biologics Doses First Patient in IBI363 Melanoma Study vs Keytruda
China-based Innovent Biologics, Inc. (HKG: 1801) announced the first patient dosing in the pivotal regulatory...